Switzer TV

Just as the language of love is poetry, the language of the market is charts - and lots of them.

This week our Chartist-in-residence, Michael Gable from Fairmont Equities, breaks down the market to give us an in-depth view of what might just be the beginning of the end of CBA's share price dominance. Did you know that after touching new highs late last week of $192 per share, it has since fallen to $177? Will it keep falling?

PLUS: Paul Rickard joins us to speculate on why it's time to look at resources stocks instead of bank stocks thanks to Australia's super funds, and we preview tomorrow's rate cut news with a look at why Governor Bullock's statement will set the scene for the next 12 months on the markets.

 

Subscribe to Switzer

  • Switzer Report - https://switzerreport.com.au/subscribe
  • Switzer Daily - https://switzer.com.au/subscribe
Switzer Investing TV | 7 July 2025: is CBA's legendary share price run over? Our experts say yes

Just as the language of love is poetry, the language of the market is charts - and lots of them. This week our Chartist-in-residence, Michael Gable from Fairmont Equities, breaks down the market to give us an in-depth view of what might just be the beginning of the end of CBA's share price dominance. Did you know that after touching new highs late last week of $192 per share, it has since fallen to $177? Will it keep falling?

More videos

3 hot value stocks + CEO of iSelect, buy or not & house price boom to die?

Roger Montgomery from Montgomery Investment Management, Warren Hebard from iSelect, Michael Knox from Morgans and Paul Rickard from Switzer join the show.

Series:
Mad about Money Live

Join Peter Switzer and Paul Rickard for the latest live episode of Mad about Money.

Series:
It’s time to hunt for value stocks, try these: CSL, RMD, BHP, WPL + BHP a buy?

Peter Switzer speaks to Julia Lee from Burman Invest, Adam Dawes from Shaw and Partners, Michael Gable from Fairmont Equities and Paul Rickard from Switzer.

Series:
Basal cancer and the treatments that have risen due to COVID-19

Dr Ross Walker discusses research on basal cell cancer treatment that is similar to the COVID-19 vaccine.

Series:
6 top stocks from fund manager and broker + house price boom exaggerated?

Prime Value Asset Management's ST Wong, Morgans' Raymond Chan, Century 21's Charles Tarbey and Coolabah Capital's Ying Yi Ann Cheng join Peter Switzer.

Series:
Mad about Money Live

Peter Switzer and Paul Rickard discuss the big money stories of the day and how they will affect you.

Series:
Graham Kelly from Noxopharm Limited (ASX:NOX)

Peter Switzer speaks to Graham Kelly, the founder, CEO and managing director of Noxopharm (NOX).

Series:
Stocks being dumped that are long term buys: CSL, DMP, JBH & 4 great income stocks

Burman Invest's Julia Lee, Tribeca's Jun Bei Liu, Switzer's Paul Rickard and Spacetalk's Mark Fortunatow join the show.

Series:
The benefits of drinking coffee and tea every day

Last week Dr Ross told us what happens when diabetics have coffee and tea every day, but what are the benefits for non-diabetics?

Series:
Hot tech stocks – MP1, NXL + could stocks fall 10%? & CEO of Aussie Home Loan

Peter Switzer is joined by Michael Wayne from Medallion Financial Group, Kieran Davies from Coolabah Capital and James Symond from Aussie Home Loans.

Series:
Mad about Money Live

Join Peter Switzer and Paul Rickard for our latest live episode of Mad about Money.

Series:
We shine the spotlight on these quality ASX stocks: ALU, BHP, MQG, CSL, TLS & more!

Julia Lee from Burman Invest, Adam Dawes from Shaw and Partners, Michael Gable from Fairmont Equities and Paul Rickard join Peter Switzer.

Series:
1 33 34 35 36 37 50

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram